Andrew James Belfield

Title: Andrew James Belfield: Innovator in Histone Deacetylase Inhibitors

Introduction

Andrew James Belfield is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of histone deacetylase inhibitors. With a total of 2 patents to his name, his work is crucial in the treatment of cell proliferative diseases, including cancers.

Latest Patents

Belfield's latest patents include innovative compounds that serve as inhibitors of histone deacetylase. These compounds, described by specific formulas, are designed to be effective in treating various cancers. The patents detail the structural components of these compounds, including the divalent radicals and ring systems that play a vital role in their functionality.

Career Highlights

Throughout his career, Andrew James Belfield has worked with prominent companies in the pharmaceutical industry. Notable among these are Chroma Therapeutics Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to refine his expertise in drug development and patenting.

Collaborations

Belfield has collaborated with several professionals in his field, including Sanjay Ratilal Patel and David Festus Charles Moffat. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Andrew James Belfield is a distinguished inventor whose work in histone deacetylase inhibitors has the potential to impact cancer treatment significantly. His contributions to medicinal chemistry and collaboration with industry leaders highlight his importance in the field.